Korean Journal of Nephrology 1996;15(3):434-438.
Rifampin에 의한 용혈성 빈혈 간손상 급성 신부전 1예
박의련 , 최승욱 , 강남규 , 윤도식 , 김효열 , 한병근 , 이광훈 , 양경무 , 홍순원
Abstract
Rifampin is used widely in the treatment of tuberculosis. Hepatotoxic jaundice, thrombocytopenia, hemolysis and renal failure is a rare and severe complication associated with the nse of rifampin. Recently, we experienced a case of hemolytic ane- mia, acute renal failure and hepatitis due to rifampin. A 57 years old female took intermittent antituberculosis drugs including rifampin since she bda been diagnosed as renal tuberculosis one year ago and she developed acute renal failure, intravascular hemolysis, and hepatitis after recent readministration of rifampin. Kidney and liver biopsy revealed acute tubular necrosis and acute hepatitis with cholestasis. The rifampin dependent antibodies were also identified by indirect antiglobulin test in the presence of rifampin. She recovered slowly after discontinution of rifampin and intensive medical care. So we report this case with a brief review of literature.
TOOLS
METRICS Graph View
  • 317 View
  • 13 Download
Related articles


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail: registry@ksn.or.kr                

Copyright © 2024 by The Korean Society of Nephrology.

Developed in M2PI

Close layer